SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,768 | -7.8% | 1,406,158 | +0.5% | 0.39% | -2.5% |
| Q2 2023 | $42,062 | -18.0% | 1,399,255 | -1.2% | 0.40% | -19.7% |
| Q1 2023 | $51,306 | +2.3% | 1,416,104 | +0.7% | 0.50% | -2.4% |
| Q4 2022 | $50,171 | -99.9% | 1,406,528 | -20.4% | 0.51% | -22.9% |
| Q3 2022 | $59,830,000 | +8.3% | 1,767,489 | -7.5% | 0.66% | +10.7% |
| Q2 2022 | $55,232,000 | -6.5% | 1,909,849 | +4.5% | 0.60% | +13.3% |
| Q1 2022 | $59,052,000 | +10.3% | 1,827,091 | -0.5% | 0.53% | +17.4% |
| Q4 2021 | $53,551,000 | +23.5% | 1,836,466 | +13.0% | 0.45% | +15.8% |
| Q3 2021 | $43,352,000 | -12.9% | 1,625,490 | +0.6% | 0.39% | -10.6% |
| Q2 2021 | $49,760,000 | +20.8% | 1,616,100 | +2.7% | 0.43% | +14.2% |
| Q1 2021 | $41,192,000 | +24.3% | 1,573,411 | +19.4% | 0.38% | +8.9% |
| Q4 2020 | $33,144,000 | +51.5% | 1,317,340 | +25.5% | 0.35% | +21.7% |
| Q3 2020 | $21,880,000 | +16.5% | 1,049,888 | +32.8% | 0.29% | +8.3% |
| Q2 2020 | $18,782,000 | – | 790,801 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |